Apoptosis of cells must be regulated both positively and negatively in response to a variety of stimuli in the body. Various environmental stresses are known to initiate apoptosis via differential signal transduction cascades. However, induction of signals that may inhibit apoptosis is poorly understood, although a number of intracellular molecules that mediate inhibition of apoptosis have been identified. Here we present a novel murine macrophage-specific 54-kD secreted protein which inhibits apoptosis (termed AIM, for apoptosis inhibitor expressed by macrophages). AIM belongs to the macrophage scavenger receptor cysteine-rich domain superfamily (SRCR-SF), members of which share a highly homologous conserved cysteine-rich domain. In AIM-deficient mice, the thymocyte numbers were diminished to half those in wild-type mice, and CD4/CD8 double-positive (DP) thymocytes were strikingly more susceptible to apoptosis induced by both dexamethasone and irradiation in vivo. Recombinant AIM protein significantly inhibited cell death of DP thymocytes in response to a variety of stimuli in vitro. These results indicate that in the thymus, AIM functions in trans to induce resistance to apoptosis within DP cells, and thus supports the viability of DP thymocytes before thymic selection.
Skip Nav Destination
Article navigation
18 January 1999
Article|
January 18 1999
Increased Susceptibility of Thymocytes to Apoptosis in Mice Lacking AIM, a Novel Murine Macrophage-derived Soluble Factor Belonging to the Scavenger Receptor Cysteine-rich Domain Superfamily
Toru Miyazaki,
Toru Miyazaki
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; the ‡Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-8655, Japan; and the §Second Department of Pathology, Niigata University School of Medicine, Niigata 951-8510, Japan
Search for other works by this author on:
Yumiko Hirokami,
Yumiko Hirokami
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; the ‡Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-8655, Japan; and the §Second Department of Pathology, Niigata University School of Medicine, Niigata 951-8510, Japan
Search for other works by this author on:
Nobuyuki Matsuhashi,
Nobuyuki Matsuhashi
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; the ‡Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-8655, Japan; and the §Second Department of Pathology, Niigata University School of Medicine, Niigata 951-8510, Japan
Search for other works by this author on:
Hisakazu Takatsuka,
Hisakazu Takatsuka
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; the ‡Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-8655, Japan; and the §Second Department of Pathology, Niigata University School of Medicine, Niigata 951-8510, Japan
Search for other works by this author on:
Makoto Naito
Makoto Naito
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; the ‡Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-8655, Japan; and the §Second Department of Pathology, Niigata University School of Medicine, Niigata 951-8510, Japan
Search for other works by this author on:
Toru Miyazaki
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; the ‡Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-8655, Japan; and the §Second Department of Pathology, Niigata University School of Medicine, Niigata 951-8510, Japan
Yumiko Hirokami
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; the ‡Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-8655, Japan; and the §Second Department of Pathology, Niigata University School of Medicine, Niigata 951-8510, Japan
Nobuyuki Matsuhashi
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; the ‡Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-8655, Japan; and the §Second Department of Pathology, Niigata University School of Medicine, Niigata 951-8510, Japan
Hisakazu Takatsuka
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; the ‡Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-8655, Japan; and the §Second Department of Pathology, Niigata University School of Medicine, Niigata 951-8510, Japan
Makoto Naito
From the *Basel Institute for Immunology, CH-4005 Basel, Switzerland; the ‡Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo 113-8655, Japan; and the §Second Department of Pathology, Niigata University School of Medicine, Niigata 951-8510, Japan
Address correspondence to Toru Miyazaki, The Basel Institute for Immunology, Grenzacherstrasse 487, postfach CH-4005, Basel, Switzerland. Phone: 41-61-605-1303; Fax: 41-61-605-1364; E-mail: [email protected]
The Basel Institute for Immunology was founded and is supported by F. Hoffman-La Roche Ltd. (Basel, Switzerland).
Received:
October 06 1998
Online ISSN: 1540-9538
Print ISSN: 0022-1007
1999
J Exp Med (1999) 189 (2): 413–422.
Article history
Received:
October 06 1998
Citation
Toru Miyazaki, Yumiko Hirokami, Nobuyuki Matsuhashi, Hisakazu Takatsuka, Makoto Naito; Increased Susceptibility of Thymocytes to Apoptosis in Mice Lacking AIM, a Novel Murine Macrophage-derived Soluble Factor Belonging to the Scavenger Receptor Cysteine-rich Domain Superfamily . J Exp Med 18 January 1999; 189 (2): 413–422. doi: https://doi.org/10.1084/jem.189.2.413
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement